WEEK 8 - Microbiology, Pathogenesis and Immunology of HIV infection Flashcards

1
Q

HIV INFO

Inc. what it affects, how it was spread

A
  • Its a retrovirus (produces DNA from RNA)
    • works backwards = KEY virulence factor
    • 2 types: HIV-1 (more virulent) and HIV-2
  • Virus has a high mutation rate
    • virus adapts rapidly + becomes mroe virulent
  • Primarily infects CD4+ T cells, macrophages and dendritic cells
  • HIV spread from primates (animals) to humans
  • HIV has been around since ealry 1900s but didnt know much about it till 1980s when there was an ↑ in human cases
    - especially amongst young, healthy males who were dying from opportunistic infections
    - prompted research where it was discovered
  • HIV is a global infection, but is predominant in Sub-Saharan Africa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 2 Types of immunodeficiency?

A
  1. Primary immunodeficiency
    - acquried from birth
  2. Secondary immunodeficiency
    - acquired from secondary factors

Both types lead to immune response being affected negatively e.g.
- Lack of B-cell maturation = ↓ antibody function
- Altered T cell and phagocyte function
-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Primary Immunodeficiencies

A

Are acquried from birth

  • Are caused by mutations affecting genes that control the expression + activity of immune responses
    - e.g. antibody expression, T-cells and phagocyte function
    - includes innate + adaptive immunity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Secondary Immunodeficiencies

A

Are acquired as a consequence from secondary factors

Secondary factors include:
- Environmental
- Diseases e.g. viral infections (e.g. AIDS)
- Starvation or malnutrition (e.g. Fe deficiency)
- Medical intervention (e.g. x-rays, corticosteroids)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Acquired Immuno-Deficiency Syndrome (AIDS) INFO

Example of a Secondary Immunodeficiency

A

Virus is airbone + resides in blood

Transmission:
- Sexual contact
- Vertical (from mother to baby)
- Direct contact with HIV infected blood (must have open cuts / wounds)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Typical course of HIV infection

i.e. process of HIV infection in body (timeframes)

A
  1. Have contact with HIV-infected individual
  2. Develop flu-like symptoms in first 2-6 weeks post-exposure AND a rapid ↓ in CD4 T cells (< 500)
    • e.g. fever, tired, malaise, joint pain
    • drop in CD4 levels as body has no immunity against the infection
    • patient will have HIGH VIRAL LOAD
    • in this period patient WILL get a POSITVE HIV test RESULT
  3. After 6 weeks have inital ↑ in CD4 T cells
    • T cells last several years = infection is latent in body
    • asymptomatic phase (have no symptoms) can last 10-20 years
    • gradual ↓ in CD4 (over years)
    • have STABLE VIRAL LOAD
  4. After asymptomatic phase have BIG ↓ in CD4 T cells as viral load ↑
    • ↓ 500 = symptomatic phase
    • ↓ 200 = AIDS acquired
      - CRITICAL VALUE
    • ↓ 100 = terminal decline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HIV Virus Structure

Key proteins + their function

A
  1. Glycoproteins (GPs) - on virus syrface
    • GP120 - allows HIV to attach to host cell (adhesion)
    • GP41 - facilitates fusion between virus + host (fusion)
  2. Capsid is composed of p24 protein
    - Encapsualted in centre is the single viral RNA strand
    - Has NO DNA
  3. Envelope is composed of p17 protein
  4. p10 protease - facilitates maturation of virus
  5. p64 (reverse transcriptase) - enzyme
    - mediates the reversal translation of RNA to DNA
    - expresses viral proteins
    - KEY virulent factor (as many human cells do NOT have this enzyme)
    - uses this to produce viral DNA
  6. Integrase (enzyme)
    - allows viral cDNA to integrate into host cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mechanism of HIV infection

i.e. pathogenesis / life cycle

A
  1. Virus comes into contact with host CD4 receptors (on T cell surface) and Co-receptor (CXCR4 or CCR5)
    • GP120 binds to CD4+ receptor forming a complex causing release of GP41
    • co-receptors bind to cytokines
  2. Release of GP41 causes fusion of host cell + virus
    • viral genome (RNA) released into host cell cytoplasm as the viral envelope dissociates
  3. Virus starts prodcuing RT
    • single strand RNA is reversed into viral cDNA (by reverse transcriptase / RT)
    • viral cDNA is integrated into host DNA (by integrase enzyme)
      = provirus formed
  4. Activation of CD4+ T cell induces transcription factors (e.g. NFkB)
    • NFkB activates transcription of viral genome + produces viral proteins
    • NFkB produces pro-inflammatory cytokines
  5. Viral proteins
    - Tat - amplifies transcription (copying DNA into a RNA strand) of viral RNA
    - Rev - transports viral RNA to cytoplasm
    - GP160 - (GP120 + GP41)
    - Polymerase - reverse transcriptase (make DNA from RNA)
    - Gag - express proteins which from capsid + envelope (that protects viral genome)
  6. Virus makes more copies of itself
  7. Virus buds from the cell + is released
  8. Maturation occurs (protease cleaves pre-protein)
  9. Mature virus infects other host CD4+ cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Tropism and Reverse Transcriptase

A

Tropism relates to what receptor the virus has more affintiy for

  • Virus can bind to co-receptor CXCR4 or CCR5 on the T cell
  • Some HIV are more virulent depending on what they bind to
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Explain HIV immune evasion process

A
  • HIV has a rapid mutation rate (in reverse transcriptase) = helps evade host immune repsonse
  • HIV downregulates MHC-1 molecules = ↓ T-cell function
  • HIV resides in CD4+ T cells (host) = difficult for immune system to detect + eliminate virus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The immune system of a HIV-infected (immunocompromised) patient

i.e. how HIV affects the immune system

A
  • ↓ CD4+ T cell count over time
    - Virus binds to CD4+ receptor and CXCR4 co-receptor = function of T cells is stopped
    - virus binding degrades T cells = apoptosis / death = ↓ in no.
    - T cells produce cytokines which bring aveolar macrophages to respiratory tract = virus spreads in lung
  • Functional deficiency in CD4+ and CD8+ T cells and Natural killer (NK) cells
    - immune system impaired = susceptible to opportunistic infections
  • Impaired macrophage and neutrophil function
    - macrophages + T cells produce cytokines whcih bring neutrophils to area of infection
  • May develop cancers due to random insertion of viral genome within cells of host = increases potential of mutation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Opportunisitic Infections and Co-infections

A

In HIV patients will see infections that wouldn’t cause serious issues in healthy individuals

Opportunisitc Infections Examples:
- TB
- Skin cancer (kaposi’s sarcoma)
- Pneumocystis pneumonia

NOTE:
- These infections are used as diagnsotic factors for HIV / AIDS
- as the infections are only common in people with low CD4 count

Co-Infections
- HIV may occur alongside TB, hepatitis B or C, STIs
- If have HIV and Hepatitis = more likely to die from infection
- these 2 conditions have strong association

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Current and emerging Anti-retroviral therapies (ARTs) and the AIM of treatment

4 ARTs

A
  1. Fusion Inhibitors / CCR5 inhbitors
  2. Reverse Transcriptase Inhibitors (RTIs)
  3. Integrase Inhibitors
  4. Protease Inhibitors

OTHER:
- Sexual protection e.g. condoms
- Physical protection e.g. gloves, goggles etc. when handling blood borne viruses
- Prevent vertical transmission

AIM:
- Keep CD4+ T cell count as high as possible (>350)
- Once CD4 levels decline can’t get them back
- ↓ viral load to undetectable levels
- Early detection, treatment, and prevention

NOTE:
- Patients are given a combo of drugs to target diff. virulence factors / steps in HIV life cycle
- NOT CURATIVE treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Fusion Inhibitors / CCR5 inhbitors

ARTs

A
  • Prevent attachment of virus to host cell
  • Prevent interaction between GP and CD4+ receptors and CXCR4 co-receptors on T cells
  • Use of small molecules / antibodies to bind to receptor preventing virus from being able to bind
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Reverse Transcriptase Inhibitors (RTIs)

ARTs

A
  • Prevent formation of viral cDNA
    - prevents conversion of viral RNA into viral cDNA
  • Inhbit RT = NO viral DNA produced = no viral genome integrated into host cell
  • e.g. Nucleosides (chain terminators) / NRTIs: AZT, DDT, etc.
  • e.g. Non nucleoside inhibitors / NNRTIs (Nevirapine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Integrase Inhibitors

ARTs

A
  • Prevent integration of viral DNA into host genome
    • e.g. INSTIs
  • When viral DNA is integrated into host genome that is PERMANENT
    • we can NOT reverse this with drugs
17
Q

Protease Inhibitors

ARTs

A
  • Prevent expression of viral proteins + virions and maturation of viral cell
  • Protease cleaves pre-proteins into mature proteins which facilitate formation of capsid + envelope
18
Q

What are the problems with ARTs

A
  • Harder to develop drugs targeting virus factors after viral replication and assembly has occured
    - e.g. targetting translation into viral proteins, budding etc.
    - only have protease inhbitors currently
  • Drug resistance developing
    • virus can adjust to inhibition + find ways to overcome ARVs
    • HIV has high mutation rate = targets change e.g. RT, integrase, portease
  • Poor adherance to meds = poor viral suppression
    = viral load remains ↑ + CD4 cell count ↓
    - QoL ↓ and ↑ risk of viral transmission
  • Latent reservoirs
    - HIV can remain latent in body for 10+ years = can NOT target virus if its not replicating
  • Resistance
    - Primary Resistance = infected with a drug resistant HIV strain
    - Secondary Resistance =resitance develops AFTER ARV use

NOTE:
NEED Combination Therapies to combat problem
- Increased effectiveness at inhibition of replication
- Markedly reduced development of resistance

19
Q

How can we prevent HIV Transmission

2 Treatments

A
  1. ## PrEP (Pre-exposure Prophylaxis)
  2. PEP (Post-esposure Prophylaxis)

OTHER:
- Safe sex
- Harm reduction e.g. not sharing needles

20
Q

Why has an AIDS vaccine not been developed?

A
  • Most effective vaccines are whole-killed or live-attenuated organisms, killed HIV-1 does not retain antigenicity and live has too many safety issues
  • Most vaccines protect against disease, not against infection
  • Vaccines mimic natural immunity against re-infection seen in people that have recovered from infection but NO one has recovered from AIDS
  • Most vaccines protect for years against viruses that change very little over time but HIV-1 mutates at a rapid rate
21
Q

What are current HIV / AIDS cure strategies

(research)

A
  • Stem cell transplant
  • Sterilising cure
    - complete eradication of HIV from body inc. ALL latent reservoirs + actively replicating virus = NO virus particles left
  • Shock and Kill
    - forces HIV out of reservoirs using latency reversing agents
  • Block and Lock
    - locks HIV in dormancy by editing the genes in the HIV genome